ZA200506074B - Substitution derivatives of N6-benzyladenosine, methods of their preparation, their use for preperation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds - Google Patents
Substitution derivatives of N6-benzyladenosine, methods of their preparation, their use for preperation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds Download PDFInfo
- Publication number
- ZA200506074B ZA200506074B ZA200506074A ZA200506074A ZA200506074B ZA 200506074 B ZA200506074 B ZA 200506074B ZA 200506074 A ZA200506074 A ZA 200506074A ZA 200506074 A ZA200506074 A ZA 200506074A ZA 200506074 B ZA200506074 B ZA 200506074B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydroxy
- purine riboside
- chloro
- fluoro
- amino
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 72
- 238000002360 preparation method Methods 0.000 title claims description 32
- 238000000034 method Methods 0.000 title claims description 24
- 238000006467 substitution reaction Methods 0.000 title claims description 24
- 239000003814 drug Substances 0.000 title claims description 17
- 239000003630 growth substance Substances 0.000 title claims description 16
- 229940079593 drug Drugs 0.000 title claims description 14
- 239000002537 cosmetic Substances 0.000 title claims description 13
- MRPKNNSABYPGBF-LSCFUAHRSA-N (2r,3r,4s,5r)-2-[6-(benzylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C=CC=CC=3)=C2N=C1 MRPKNNSABYPGBF-LSCFUAHRSA-N 0.000 title claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 title description 2
- -1 amino, hydrazo Chemical group 0.000 claims description 936
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 claims description 643
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 112
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 108
- 210000004027 cell Anatomy 0.000 claims description 107
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 100
- 125000004432 carbon atom Chemical group C* 0.000 claims description 91
- 125000001153 fluoro group Chemical group F* 0.000 claims description 88
- 150000008223 ribosides Chemical class 0.000 claims description 88
- 125000001424 substituent group Chemical group 0.000 claims description 87
- 125000000217 alkyl group Chemical group 0.000 claims description 67
- 125000003118 aryl group Chemical group 0.000 claims description 47
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 46
- 125000001246 bromo group Chemical group Br* 0.000 claims description 42
- 125000003368 amide group Chemical group 0.000 claims description 39
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 39
- 125000004423 acyloxy group Chemical group 0.000 claims description 36
- 125000003545 alkoxy group Chemical group 0.000 claims description 36
- 125000003282 alkyl amino group Chemical group 0.000 claims description 36
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 36
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 36
- 125000004414 alkyl thio group Chemical group 0.000 claims description 35
- 125000004442 acylamino group Chemical group 0.000 claims description 34
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 34
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 31
- 125000000304 alkynyl group Chemical group 0.000 claims description 29
- 125000003342 alkenyl group Chemical group 0.000 claims description 27
- 125000001072 heteroaryl group Chemical group 0.000 claims description 25
- 229910052799 carbon Inorganic materials 0.000 claims description 24
- 229910052757 nitrogen Inorganic materials 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 19
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 19
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 18
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 18
- 125000003107 substituted aryl group Chemical group 0.000 claims description 18
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 17
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 16
- 125000005842 heteroatom Chemical group 0.000 claims description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims description 16
- 125000003367 polycyclic group Chemical group 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 16
- 125000002950 monocyclic group Chemical group 0.000 claims description 14
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 14
- 125000004429 atom Chemical group 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 9
- 125000004122 cyclic group Chemical group 0.000 claims description 8
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 230000009758 senescence Effects 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 125000004437 phosphorous atom Chemical group 0.000 claims description 7
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 claims description 6
- 125000002837 carbocyclic group Chemical group 0.000 claims description 6
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 6
- 210000002950 fibroblast Anatomy 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical group 0.000 claims description 6
- 125000005561 phenanthryl group Chemical group 0.000 claims description 6
- 230000035755 proliferation Effects 0.000 claims description 6
- CZNHDIGYWBRFEK-UHFFFAOYSA-N 2-methoxy-6-[(7h-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O CZNHDIGYWBRFEK-UHFFFAOYSA-N 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 5
- 206010052779 Transplant rejections Diseases 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- IOPUAMVSOMUEDA-UHFFFAOYSA-N 2,5-dimethoxy-4-[(7h-purin-6-ylamino)methyl]phenol Chemical compound C1=C(O)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1OC IOPUAMVSOMUEDA-UHFFFAOYSA-N 0.000 claims description 4
- LFLSCGLVSMEKGW-UHFFFAOYSA-N 2-methoxy-4-[(7h-purin-6-ylamino)methyl]phenol Chemical compound C1=C(O)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 LFLSCGLVSMEKGW-UHFFFAOYSA-N 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- DRFDMBPPWUNZFX-UHFFFAOYSA-N [2-[(7h-purin-6-ylamino)methyl]phenyl] acetate Chemical compound CC(=O)OC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 DRFDMBPPWUNZFX-UHFFFAOYSA-N 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 239000004305 biphenyl Substances 0.000 claims description 4
- 235000010290 biphenyl Nutrition 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- HTFODAFEUYNHMV-UHFFFAOYSA-N n-[(2-chloro-4-fluorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC(F)=CC=C1CNC1=NC=NC2=C1NC=N2 HTFODAFEUYNHMV-UHFFFAOYSA-N 0.000 claims description 4
- UIPBJXUABCBASK-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 UIPBJXUABCBASK-UHFFFAOYSA-N 0.000 claims description 4
- UTZWZZICQOYTFM-UHFFFAOYSA-N n-[(3-chloro-2,6-difluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC=C(Cl)C(F)=C1CNC1=NC=NC2=C1NC=N2 UTZWZZICQOYTFM-UHFFFAOYSA-N 0.000 claims description 4
- PGPCCTUFQQKBIZ-UHFFFAOYSA-N n-[(4-ethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(OCC)=CC=C1CNC1=NC=NC2=C1NC=N2 PGPCCTUFQQKBIZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- QMXCKKNYBDZYHP-UHFFFAOYSA-N 1-[2-[(7h-purin-6-ylamino)methyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 QMXCKKNYBDZYHP-UHFFFAOYSA-N 0.000 claims description 3
- KFYXVCOVDDKZIG-UHFFFAOYSA-N 2-[(7h-purin-6-ylamino)methyl]benzene-1,4-diamine Chemical compound NC1=CC=C(N)C(CNC=2C=3NC=NC=3N=CN=2)=C1 KFYXVCOVDDKZIG-UHFFFAOYSA-N 0.000 claims description 3
- PWMMSLFZXFQHQW-UHFFFAOYSA-N 4-[(7h-purin-6-ylamino)methyl]benzene-1,2,3-triol Chemical compound OC1=C(O)C(O)=CC=C1CNC1=NC=NC2=C1NC=N2 PWMMSLFZXFQHQW-UHFFFAOYSA-N 0.000 claims description 3
- FURPLLPJUBDPRU-UHFFFAOYSA-N 4-[(7h-purin-6-ylamino)methyl]benzene-1,2-diol Chemical compound C1=C(O)C(O)=CC=C1CNC1=NC=NC2=C1NC=N2 FURPLLPJUBDPRU-UHFFFAOYSA-N 0.000 claims description 3
- FSWKTTPUDCDRQF-UHFFFAOYSA-N 4-methoxy-5-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound COC1=C(O)C=C(O)C=C1CNC1=NC=NC2=C1NC=N2 FSWKTTPUDCDRQF-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 208000024827 Alzheimer disease Diseases 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 201000005569 Gout Diseases 0.000 claims description 3
- 201000004681 Psoriasis Diseases 0.000 claims description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 230000002927 anti-mitotic effect Effects 0.000 claims description 3
- 230000003308 immunostimulating effect Effects 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 206010025135 lupus erythematosus Diseases 0.000 claims description 3
- 230000000394 mitotic effect Effects 0.000 claims description 3
- 201000006417 multiple sclerosis Diseases 0.000 claims description 3
- ZFYJOAYCXBYSFO-UHFFFAOYSA-N n-[(2,3,5-trichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC(Cl)=C(Cl)C(CNC=2C=3NC=NC=3N=CN=2)=C1 ZFYJOAYCXBYSFO-UHFFFAOYSA-N 0.000 claims description 3
- IPTZAGPLYVGZBK-UHFFFAOYSA-N n-[(2-methyl-5-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=C([N+]([O-])=O)C=C1CNC1=NC=NC2=C1NC=N2 IPTZAGPLYVGZBK-UHFFFAOYSA-N 0.000 claims description 3
- REGPXSZEDITJKW-UHFFFAOYSA-N n-[(3-fluoro-4-methylphenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(F)C(C)=CC=C1CNC1=NC=NC2=C1NC=N2 REGPXSZEDITJKW-UHFFFAOYSA-N 0.000 claims description 3
- YCDLTWDQNHQKPG-UHFFFAOYSA-N n-[(3-fluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 YCDLTWDQNHQKPG-UHFFFAOYSA-N 0.000 claims description 3
- PWBBVABVBNINRX-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(Cl)=CC=C1CNC1=NC=NC2=C1NC=N2 PWBBVABVBNINRX-UHFFFAOYSA-N 0.000 claims description 3
- 208000030761 polycystic kidney disease Diseases 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 208000037803 restenosis Diseases 0.000 claims description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 3
- 230000000638 stimulation Effects 0.000 claims description 3
- 230000001629 suppression Effects 0.000 claims description 3
- QKAZZGOALRRZIZ-UHFFFAOYSA-N 1-[3-[(7h-purin-6-ylamino)methyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 QKAZZGOALRRZIZ-UHFFFAOYSA-N 0.000 claims description 2
- LTRKHMLOGIPCHM-UHFFFAOYSA-N 2,3-dimethoxy-6-[(7H-purin-6-ylamino)methyl]phenol Chemical compound OC1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 LTRKHMLOGIPCHM-UHFFFAOYSA-N 0.000 claims description 2
- QUNVNPVYAFZWKJ-UHFFFAOYSA-N 2,4-dimethoxy-6-[(7h-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O QUNVNPVYAFZWKJ-UHFFFAOYSA-N 0.000 claims description 2
- KLAFRFHICUEWKS-UHFFFAOYSA-N 2-[(7h-purin-6-ylamino)methyl]benzene-1,4-diol Chemical compound OC1=CC=C(O)C(CNC=2C=3NC=NC=3N=CN=2)=C1 KLAFRFHICUEWKS-UHFFFAOYSA-N 0.000 claims description 2
- MXRKRIWYTXSKRU-UHFFFAOYSA-N 2-[(7h-purin-6-ylamino)methyl]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 MXRKRIWYTXSKRU-UHFFFAOYSA-N 0.000 claims description 2
- NVPDWQDWHPZFHG-UHFFFAOYSA-N 2-chloro-5-[(7h-purin-6-ylamino)methyl]benzene-1,4-diol Chemical compound C1=C(Cl)C(O)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O NVPDWQDWHPZFHG-UHFFFAOYSA-N 0.000 claims description 2
- YEDYIWLGLKTTFX-UHFFFAOYSA-N 2-chloro-6-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=C(Cl)C=CC=C1CNC1=NC=NC2=C1NC=N2 YEDYIWLGLKTTFX-UHFFFAOYSA-N 0.000 claims description 2
- VYGWXXFJMDGVMU-UHFFFAOYSA-N 2-iodo-6-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=C(I)C=CC=C1CNC1=NC=NC2=C1NC=N2 VYGWXXFJMDGVMU-UHFFFAOYSA-N 0.000 claims description 2
- UKJPLRWCDVVIFM-UHFFFAOYSA-N 2-methoxy-5-[(7H-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound C1=C(O)C(OC)=C(O)C=C1CNC1=NC=NC2=C1NC=N2 UKJPLRWCDVVIFM-UHFFFAOYSA-N 0.000 claims description 2
- XOIWHPLKTWSRML-UHFFFAOYSA-N 2-methoxy-5-[(7h-purin-6-ylamino)methyl]benzene-1,4-diol Chemical compound C1=C(O)C(OC)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 XOIWHPLKTWSRML-UHFFFAOYSA-N 0.000 claims description 2
- RIQYCXBBKOQNJX-UHFFFAOYSA-N 2-methoxy-5-[(7h-purin-6-ylamino)methyl]phenol Chemical compound C1=C(O)C(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 RIQYCXBBKOQNJX-UHFFFAOYSA-N 0.000 claims description 2
- FSQIRDQZWWWQGT-UHFFFAOYSA-N 3,5-dimethoxy-4-[(7H-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC(O)=CC(OC)=C1CNC1=NC=NC2=C1NC=N2 FSQIRDQZWWWQGT-UHFFFAOYSA-N 0.000 claims description 2
- BZSRXUWTKZZZJO-UHFFFAOYSA-N 3-[(7h-purin-6-ylamino)methyl]benzaldehyde Chemical compound O=CC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 BZSRXUWTKZZZJO-UHFFFAOYSA-N 0.000 claims description 2
- AZQYVBDOVJDZTD-UHFFFAOYSA-N 3-[(7h-purin-6-ylamino)methyl]benzonitrile Chemical compound N#CC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 AZQYVBDOVJDZTD-UHFFFAOYSA-N 0.000 claims description 2
- QNDPIPZKRVZIRU-UHFFFAOYSA-N 3-bromo-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC=CC(Br)=C1CNC1=NC=NC2=C1NC=N2 QNDPIPZKRVZIRU-UHFFFAOYSA-N 0.000 claims description 2
- QMXRUBPJZUPHNM-UHFFFAOYSA-N 3-iodo-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC=CC(I)=C1CNC1=NC=NC2=C1NC=N2 QMXRUBPJZUPHNM-UHFFFAOYSA-N 0.000 claims description 2
- WUPFHHUPRKADAQ-UHFFFAOYSA-N 3-methoxy-5-[(7H-purin-6-ylamino)methyl]benzene-1,2-diol Chemical compound OC1=C(O)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 WUPFHHUPRKADAQ-UHFFFAOYSA-N 0.000 claims description 2
- OFHWDECSSWZTOD-UHFFFAOYSA-N 3-methoxy-5-[(7h-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC(O)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 OFHWDECSSWZTOD-UHFFFAOYSA-N 0.000 claims description 2
- NVOLLICEDPMHSY-UHFFFAOYSA-N 4,6-dichloro-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=C(Cl)C=C(Cl)C(O)=C1CNC1=NC=NC2=C1NC=N2 NVOLLICEDPMHSY-UHFFFAOYSA-N 0.000 claims description 2
- DYLAHCQRDOIPEQ-UHFFFAOYSA-N 4-[(7h-purin-6-ylamino)methyl]benzenesulfonic acid Chemical compound C1=CC(S(=O)(=O)O)=CC=C1CNC1=NC=NC2=C1NC=N2 DYLAHCQRDOIPEQ-UHFFFAOYSA-N 0.000 claims description 2
- LXHUJYCSXBZFDQ-UHFFFAOYSA-N 4-[(7h-purin-6-ylamino)methyl]benzonitrile Chemical compound C1=CC(C#N)=CC=C1CNC1=NC=NC2=C1NC=N2 LXHUJYCSXBZFDQ-UHFFFAOYSA-N 0.000 claims description 2
- OZRAELIAYYDEMP-UHFFFAOYSA-N 4-methoxy-3-[(7H-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC=C(O)C=C1CNC1=NC=NC2=C1NC=N2 OZRAELIAYYDEMP-UHFFFAOYSA-N 0.000 claims description 2
- NXPMPFCVNLUMDR-UHFFFAOYSA-N 5-[(7h-purin-6-ylamino)methyl]benzene-1,2,3-triol Chemical compound OC1=C(O)C(O)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 NXPMPFCVNLUMDR-UHFFFAOYSA-N 0.000 claims description 2
- MVLNMHGIZHWTDB-UHFFFAOYSA-N 5-methoxy-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=CC(OC)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 MVLNMHGIZHWTDB-UHFFFAOYSA-N 0.000 claims description 2
- HWFCNSBMGZRRIM-UHFFFAOYSA-N 5-methoxy-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 HWFCNSBMGZRRIM-UHFFFAOYSA-N 0.000 claims description 2
- NBAVFMXDZGQOIG-UHFFFAOYSA-N 5-methyl-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC(C)=CC=C1CNC1=NC=NC2=C1NC=N2 NBAVFMXDZGQOIG-UHFFFAOYSA-N 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 108090001008 Avidin Proteins 0.000 claims description 2
- KNWSGQGDXBDCBJ-UHFFFAOYSA-N COC1=C(O)C=CC=C1CNC1=NC=NC2=C1NC=N2 Chemical compound COC1=C(O)C=CC=C1CNC1=NC=NC2=C1NC=N2 KNWSGQGDXBDCBJ-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims description 2
- 241000243251 Hydra Species 0.000 claims description 2
- URVCVGNFSZHAOA-UHFFFAOYSA-N N-6-Hydroxybenzyladenosin Natural products OC1C(O)C(CO)OC1N1C2=NC=NC(NCC=3C(=CC=CC=3)O)=C2N=C1 URVCVGNFSZHAOA-UHFFFAOYSA-N 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- UGVIXKXYLBAZND-UHFFFAOYSA-N T1-11 Natural products OC1C(O)C(CO)OC1N1C2=NC=NC(NCC=3C=CC(O)=CC=3)=C2N=C1 UGVIXKXYLBAZND-UHFFFAOYSA-N 0.000 claims description 2
- SOJWHKBXDDNTAQ-UHFFFAOYSA-N [3,5-dihydroxy-4-[(7h-purin-6-ylamino)methyl]phenyl] hypobromite Chemical compound OC1=CC(OBr)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 SOJWHKBXDDNTAQ-UHFFFAOYSA-N 0.000 claims description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 2
- MXULOXFRGWTLST-UHFFFAOYSA-N [3-acetyloxy-5-[(7h-purin-6-ylamino)methyl]phenyl] acetate Chemical compound CC(=O)OC1=CC(OC(=O)C)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 MXULOXFRGWTLST-UHFFFAOYSA-N 0.000 claims description 2
- OCQHDVQOBYPUKH-UHFFFAOYSA-N [4-[(7h-purin-6-ylamino)methyl]phenyl] acetate Chemical compound C1=CC(OC(=O)C)=CC=C1CNC1=NC=NC2=C1NC=N2 OCQHDVQOBYPUKH-UHFFFAOYSA-N 0.000 claims description 2
- 230000032683 aging Effects 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 230000019552 anatomical structure morphogenesis Effects 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 125000005242 carbamoyl alkyl group Chemical group 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 238000010367 cloning Methods 0.000 claims description 2
- 210000002308 embryonic cell Anatomy 0.000 claims description 2
- 210000001339 epidermal cell Anatomy 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 230000002538 fungal effect Effects 0.000 claims description 2
- 208000024908 graft versus host disease Diseases 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 2
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims description 2
- 238000003018 immunoassay Methods 0.000 claims description 2
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 claims description 2
- 210000002510 keratinocyte Anatomy 0.000 claims description 2
- CMTVBCOBYCGDJR-UHFFFAOYSA-N meta-topolin riboside Natural products OC1C(O)C(CO)OC1N1C2=NC=NC(NCC=3C=C(O)C=CC=3)=C2N=C1 CMTVBCOBYCGDJR-UHFFFAOYSA-N 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- KAXAQVVFOKILLK-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-5-ylmethyl)-7h-purin-6-amine Chemical compound O1CCOC2=C1C=CC=C2CNC1=NC=NC2=C1NC=N2 KAXAQVVFOKILLK-UHFFFAOYSA-N 0.000 claims description 2
- XFUDFMYXKUIWTF-UHFFFAOYSA-N n-[(2,3,4,5-tetrafluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=C(F)C(F)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1F XFUDFMYXKUIWTF-UHFFFAOYSA-N 0.000 claims description 2
- NMTRZECLZGTLQP-UHFFFAOYSA-N n-[(2,3,4-trifluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=C(F)C(F)=CC=C1CNC1=NC=NC2=C1NC=N2 NMTRZECLZGTLQP-UHFFFAOYSA-N 0.000 claims description 2
- SIOXCBAJHZBDRL-UHFFFAOYSA-N n-[(2,3,5-trifluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC(F)=C(F)C(CNC=2C=3NC=NC=3N=CN=2)=C1 SIOXCBAJHZBDRL-UHFFFAOYSA-N 0.000 claims description 2
- LZAXBIBDJQGHPM-UHFFFAOYSA-N n-[(2,3,6-trifluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC=C(F)C(CNC=2C=3NC=NC=3N=CN=2)=C1F LZAXBIBDJQGHPM-UHFFFAOYSA-N 0.000 claims description 2
- LIWWIZDXRZNWJX-UHFFFAOYSA-N n-[(2,3-dimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1OC LIWWIZDXRZNWJX-UHFFFAOYSA-N 0.000 claims description 2
- URROEQXDJFRLRN-UHFFFAOYSA-N n-[(2,3-dimethylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1C URROEQXDJFRLRN-UHFFFAOYSA-N 0.000 claims description 2
- LNEZIUBJZZKWOQ-UHFFFAOYSA-N n-[(2,4,5-trifluorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(F)C(F)=CC(F)=C1CNC1=NC=NC2=C1NC=N2 LNEZIUBJZZKWOQ-UHFFFAOYSA-N 0.000 claims description 2
- LEVMIYORERURCU-UHFFFAOYSA-N n-[(2,4,6-trichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC(Cl)=CC(Cl)=C1CNC1=NC=NC2=C1NC=N2 LEVMIYORERURCU-UHFFFAOYSA-N 0.000 claims description 2
- UGGBIVVLRPJYKC-UHFFFAOYSA-N n-[(2,4,6-trimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC(OC)=CC(OC)=C1CNC1=NC=NC2=C1NC=N2 UGGBIVVLRPJYKC-UHFFFAOYSA-N 0.000 claims description 2
- VVRFWMHUYCNZQI-UHFFFAOYSA-N n-[(2,5-dichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC=C(Cl)C(CNC=2C=3NC=NC=3N=CN=2)=C1 VVRFWMHUYCNZQI-UHFFFAOYSA-N 0.000 claims description 2
- IRBSBOZOZNUXRW-UHFFFAOYSA-N n-[(2,5-dimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC=C(OC)C(CNC=2C=3NC=NC=3N=CN=2)=C1 IRBSBOZOZNUXRW-UHFFFAOYSA-N 0.000 claims description 2
- UULDOANBEOTFRX-UHFFFAOYSA-N n-[(2,6-difluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC=CC(F)=C1CNC1=NC=NC2=C1NC=N2 UULDOANBEOTFRX-UHFFFAOYSA-N 0.000 claims description 2
- RTQZJQJEMTWXHD-UHFFFAOYSA-N n-[(2,6-dimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC=CC(OC)=C1CNC1=NC=NC2=C1NC=N2 RTQZJQJEMTWXHD-UHFFFAOYSA-N 0.000 claims description 2
- MSRRMZCNIKLFGQ-UHFFFAOYSA-N n-[(2-amino-3-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=C(Cl)C=CC=C1CNC1=NC=NC2=C1NC=N2 MSRRMZCNIKLFGQ-UHFFFAOYSA-N 0.000 claims description 2
- ZJTRLXXRFINXKP-UHFFFAOYSA-N n-[(2-amino-6-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=CC=CC(Cl)=C1CNC1=NC=NC2=C1NC=N2 ZJTRLXXRFINXKP-UHFFFAOYSA-N 0.000 claims description 2
- SPRRYSQZCZWSEW-UHFFFAOYSA-N n-[(2-aminophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 SPRRYSQZCZWSEW-UHFFFAOYSA-N 0.000 claims description 2
- YWPFTGKKYUNEIY-UHFFFAOYSA-N n-[(2-bromophenyl)methyl]-7h-purin-6-amine Chemical compound BrC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 YWPFTGKKYUNEIY-UHFFFAOYSA-N 0.000 claims description 2
- JCHFKMVDUBDVKA-UHFFFAOYSA-N n-[(2-chloro-5-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound [O-][N+](=O)C1=CC=C(Cl)C(CNC=2C=3NC=NC=3N=CN=2)=C1 JCHFKMVDUBDVKA-UHFFFAOYSA-N 0.000 claims description 2
- UDHOZRIASIKZCB-UHFFFAOYSA-N n-[(2-chloro-6-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound [O-][N+](=O)C1=CC=CC(Cl)=C1CNC1=NC=NC2=C1NC=N2 UDHOZRIASIKZCB-UHFFFAOYSA-N 0.000 claims description 2
- QMMDBDHAZWHEAR-UHFFFAOYSA-N n-[(2-ethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound CCOC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 QMMDBDHAZWHEAR-UHFFFAOYSA-N 0.000 claims description 2
- QRLIRRYFXZOVMX-UHFFFAOYSA-N n-[(2-iodophenyl)methyl]-7h-purin-6-amine Chemical compound IC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 QRLIRRYFXZOVMX-UHFFFAOYSA-N 0.000 claims description 2
- KFCRCDSFFAMAHH-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1CNC1=NC=NC2=C1NC=N2 KFCRCDSFFAMAHH-UHFFFAOYSA-N 0.000 claims description 2
- OVLYKYQZUJVBNO-UHFFFAOYSA-N n-[(3,5-dibromo-4-methoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Br)C(OC)=C(Br)C=C1CNC1=NC=NC2=C1NC=N2 OVLYKYQZUJVBNO-UHFFFAOYSA-N 0.000 claims description 2
- VOXIYPZFNDUHMG-UHFFFAOYSA-N n-[(3,5-dichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC(Cl)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 VOXIYPZFNDUHMG-UHFFFAOYSA-N 0.000 claims description 2
- QMZDBSQMBCOXFM-UHFFFAOYSA-N n-[(3,5-difluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC(F)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 QMZDBSQMBCOXFM-UHFFFAOYSA-N 0.000 claims description 2
- HHTDFGWHDCNFPF-UHFFFAOYSA-N n-[(3,5-dinitrophenyl)methyl]-7h-purin-6-amine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 HHTDFGWHDCNFPF-UHFFFAOYSA-N 0.000 claims description 2
- ADKPWLFJLWHQPB-UHFFFAOYSA-N n-[(3-amino-5-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=CC(Cl)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 ADKPWLFJLWHQPB-UHFFFAOYSA-N 0.000 claims description 2
- QAHQSHGRVZHTPN-UHFFFAOYSA-N n-[(3-aminophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 QAHQSHGRVZHTPN-UHFFFAOYSA-N 0.000 claims description 2
- RDJNXNBYFPDVMI-UHFFFAOYSA-N n-[(3-bromo-4-methoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Br)C(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 RDJNXNBYFPDVMI-UHFFFAOYSA-N 0.000 claims description 2
- WHYVKEGFJPLEJZ-UHFFFAOYSA-N n-[(3-iodophenyl)methyl]-7h-purin-6-amine Chemical compound IC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 WHYVKEGFJPLEJZ-UHFFFAOYSA-N 0.000 claims description 2
- NJUGLVUMAHIRDN-UHFFFAOYSA-N n-[(3-methylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 NJUGLVUMAHIRDN-UHFFFAOYSA-N 0.000 claims description 2
- XRBLGYUGFSEASE-UHFFFAOYSA-N n-[(3-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound [O-][N+](=O)C1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 XRBLGYUGFSEASE-UHFFFAOYSA-N 0.000 claims description 2
- AWYGFCCIJDYDTN-UHFFFAOYSA-N n-[(4-amino-3-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(N)=CC=C1CNC1=NC=NC2=C1NC=N2 AWYGFCCIJDYDTN-UHFFFAOYSA-N 0.000 claims description 2
- LGIAMFVFYKMPAN-UHFFFAOYSA-N n-[(4-bromophenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(Br)=CC=C1CNC1=NC=NC2=C1NC=N2 LGIAMFVFYKMPAN-UHFFFAOYSA-N 0.000 claims description 2
- OPHJSGHJIKFTNO-UHFFFAOYSA-N n-[(4-butoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(OCCCC)=CC=C1CNC1=NC=NC2=C1NC=N2 OPHJSGHJIKFTNO-UHFFFAOYSA-N 0.000 claims description 2
- HCMPDMFFQARTKW-UHFFFAOYSA-N n-[(4-hexoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(OCCCCCC)=CC=C1CNC1=NC=NC2=C1NC=N2 HCMPDMFFQARTKW-UHFFFAOYSA-N 0.000 claims description 2
- AXYKSADFXHVJFP-UHFFFAOYSA-N n-[(4-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CNC1=NC=NC2=C1NC=N2 AXYKSADFXHVJFP-UHFFFAOYSA-N 0.000 claims description 2
- SNKXZEZTQYQJOE-UHFFFAOYSA-N n-[(4-octoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(OCCCCCCCC)=CC=C1CNC1=NC=NC2=C1NC=N2 SNKXZEZTQYQJOE-UHFFFAOYSA-N 0.000 claims description 2
- PAHCOGCIWQVZRK-UHFFFAOYSA-N n-[(4-pentylphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(CCCCC)=CC=C1CNC1=NC=NC2=C1NC=N2 PAHCOGCIWQVZRK-UHFFFAOYSA-N 0.000 claims description 2
- HGFZDFSBFJCGCQ-UHFFFAOYSA-N n-[(4-phenoxyphenyl)methyl]-7h-purin-6-amine Chemical compound N=1C=NC=2N=CNC=2C=1NCC(C=C1)=CC=C1OC1=CC=CC=C1 HGFZDFSBFJCGCQ-UHFFFAOYSA-N 0.000 claims description 2
- UGKQGVVVVVWLGU-UHFFFAOYSA-N n-[(4-phenylmethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound N=1C=NC=2N=CNC=2C=1NCC(C=C1)=CC=C1OCC1=CC=CC=C1 UGKQGVVVVVWLGU-UHFFFAOYSA-N 0.000 claims description 2
- VTYAERABSBZTQR-UHFFFAOYSA-N n-[(4-propylphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(CCC)=CC=C1CNC1=NC=NC2=C1NC=N2 VTYAERABSBZTQR-UHFFFAOYSA-N 0.000 claims description 2
- HAVMYFMDXVLJJW-UHFFFAOYSA-N n-[(5-amino-2-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=CC=C(Cl)C(CNC=2C=3NC=NC=3N=CN=2)=C1 HAVMYFMDXVLJJW-UHFFFAOYSA-N 0.000 claims description 2
- DCFVNXCQPDWDAV-UHFFFAOYSA-N n-[(5-amino-2-methylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=C(N)C=C1CNC1=NC=NC2=C1NC=N2 DCFVNXCQPDWDAV-UHFFFAOYSA-N 0.000 claims description 2
- DOMVMABZQVETFR-UHFFFAOYSA-N n-[(5-chloro-2-fluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC=C(Cl)C=C1CNC1=NC=NC2=C1NC=N2 DOMVMABZQVETFR-UHFFFAOYSA-N 0.000 claims description 2
- ZRXBEKXNIMUCRR-UHFFFAOYSA-N n-[(5-chloro-2-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1CNC1=NC=NC2=C1NC=N2 ZRXBEKXNIMUCRR-UHFFFAOYSA-N 0.000 claims description 2
- JSYZWUXKKRSWLU-UHFFFAOYSA-N n-[[2-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)(F)C1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 JSYZWUXKKRSWLU-UHFFFAOYSA-N 0.000 claims description 2
- OGOOMRHOKJGASQ-UHFFFAOYSA-N n-[[2-(trifluoromethylsulfanyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)(F)SC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 OGOOMRHOKJGASQ-UHFFFAOYSA-N 0.000 claims description 2
- IOSZGGBRNUQIKF-UHFFFAOYSA-N n-[[2-chloro-5-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)(F)C1=CC=C(Cl)C(CNC=2C=3NC=NC=3N=CN=2)=C1 IOSZGGBRNUQIKF-UHFFFAOYSA-N 0.000 claims description 2
- UPKBNSHKKHNZKD-UHFFFAOYSA-N n-[[2-fluoro-3-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC=C(C(F)(F)F)C(F)=C1CNC1=NC=NC2=C1NC=N2 UPKBNSHKKHNZKD-UHFFFAOYSA-N 0.000 claims description 2
- KJJVMEZUFVTWFS-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 KJJVMEZUFVTWFS-UHFFFAOYSA-N 0.000 claims description 2
- WFTLEEYQWGTPCV-UHFFFAOYSA-N n-[[3-(trifluoromethoxy)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)(F)OC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 WFTLEEYQWGTPCV-UHFFFAOYSA-N 0.000 claims description 2
- QFUKIAQHZNNVKZ-UHFFFAOYSA-N n-[[4-(chloromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC(CCl)=CC=C1CNC1=NC=NC2=C1NC=N2 QFUKIAQHZNNVKZ-UHFFFAOYSA-N 0.000 claims description 2
- ARFIECKJSOFIJI-UHFFFAOYSA-N n-[[4-(difluoromethoxy)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC(OC(F)F)=CC=C1CNC1=NC=NC2=C1NC=N2 ARFIECKJSOFIJI-UHFFFAOYSA-N 0.000 claims description 2
- UJEFGMDJOFKLJR-UHFFFAOYSA-N n-[[4-(methylamino)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC(NC)=CC=C1CNC1=NC=NC2=C1NC=N2 UJEFGMDJOFKLJR-UHFFFAOYSA-N 0.000 claims description 2
- ZVEZDKBMKRTVKZ-UHFFFAOYSA-N n-[[4-(trifluoromethoxy)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC(OC(F)(F)F)=CC=C1CNC1=NC=NC2=C1NC=N2 ZVEZDKBMKRTVKZ-UHFFFAOYSA-N 0.000 claims description 2
- HZKFNJWQHIMWEO-UHFFFAOYSA-N n-[[4-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC(C(F)(F)F)=CC=C1CNC1=NC=NC2=C1NC=N2 HZKFNJWQHIMWEO-UHFFFAOYSA-N 0.000 claims description 2
- UTXPBYXYKHQEJS-UHFFFAOYSA-N n-[[4-(trifluoromethylsulfanyl)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC(SC(F)(F)F)=CC=C1CNC1=NC=NC2=C1NC=N2 UTXPBYXYKHQEJS-UHFFFAOYSA-N 0.000 claims description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 2
- 210000000287 oocyte Anatomy 0.000 claims description 2
- 238000004886 process control Methods 0.000 claims description 2
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical group [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 claims 2
- UUXDAWLFNYUUAX-UHFFFAOYSA-N n-[(2,3,6-trichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC=C(Cl)C(CNC=2C=3NC=NC=3N=CN=2)=C1Cl UUXDAWLFNYUUAX-UHFFFAOYSA-N 0.000 claims 2
- MJOQESNAYYFBCR-UHFFFAOYSA-N n-[(2,4,5-trichlorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(Cl)=CC(Cl)=C1CNC1=NC=NC2=C1NC=N2 MJOQESNAYYFBCR-UHFFFAOYSA-N 0.000 claims 2
- STWJKIOLMNHFIK-UHFFFAOYSA-N n-[(2-methoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 STWJKIOLMNHFIK-UHFFFAOYSA-N 0.000 claims 2
- KOGDZGJILJKQJY-UHFFFAOYSA-N n-[(4-methylphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(C)=CC=C1CNC1=NC=NC2=C1NC=N2 KOGDZGJILJKQJY-UHFFFAOYSA-N 0.000 claims 2
- ZCDQUZQTBXGTJN-UHFFFAOYSA-N n-[[3-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)(F)C1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 ZCDQUZQTBXGTJN-UHFFFAOYSA-N 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- HGFGRLKZWKYFBS-UHFFFAOYSA-N 1-[4-[(7h-purin-6-ylamino)methyl]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1CNC1=NC=NC2=C1NC=N2 HGFGRLKZWKYFBS-UHFFFAOYSA-N 0.000 claims 1
- CZWOGDMIUCHGMQ-UHFFFAOYSA-N 2,6-dibromo-4-[(7h-purin-6-ylamino)methyl]phenol Chemical compound C1=C(Br)C(O)=C(Br)C=C1CNC1=NC=NC2=C1NC=N2 CZWOGDMIUCHGMQ-UHFFFAOYSA-N 0.000 claims 1
- LXLNOVFJVBWOHT-UHFFFAOYSA-N 2,6-dimethyl-4-[(7h-purin-6-ylamino)methyl]phenol Chemical compound CC1=C(O)C(C)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 LXLNOVFJVBWOHT-UHFFFAOYSA-N 0.000 claims 1
- LKVNZRUBOOJTNN-UHFFFAOYSA-N 2-[(7h-purin-6-ylamino)methyl]benzaldehyde Chemical compound O=CC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 LKVNZRUBOOJTNN-UHFFFAOYSA-N 0.000 claims 1
- OOEKZBZBWMVRQD-UHFFFAOYSA-N 2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CNC1=NC=NC2=C1NC=N2 OOEKZBZBWMVRQD-UHFFFAOYSA-N 0.000 claims 1
- LCHBLEPBBKHBPJ-UHFFFAOYSA-N 2-[(7h-purin-6-ylamino)methyl]benzonitrile Chemical compound N#CC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 LCHBLEPBBKHBPJ-UHFFFAOYSA-N 0.000 claims 1
- ZSBBSICYYWGNMM-UHFFFAOYSA-N 2-bromo-6-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=C(Br)C=CC=C1CNC1=NC=NC2=C1NC=N2 ZSBBSICYYWGNMM-UHFFFAOYSA-N 0.000 claims 1
- PJKQRYFSAWJBMY-UHFFFAOYSA-N 2-fluoro-6-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=C(F)C=CC=C1CNC1=NC=NC2=C1NC=N2 PJKQRYFSAWJBMY-UHFFFAOYSA-N 0.000 claims 1
- JHIOIJOJEQODES-UHFFFAOYSA-N 3,4,5-trimethoxy-2-[(7H-purin-6-ylamino)methyl]phenol Chemical compound COC1=C(OC)C(OC)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 JHIOIJOJEQODES-UHFFFAOYSA-N 0.000 claims 1
- AUGJHQIABVOEEP-UHFFFAOYSA-N 3-methoxy-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC=CC(O)=C1CNC1=NC=NC2=C1NC=N2 AUGJHQIABVOEEP-UHFFFAOYSA-N 0.000 claims 1
- KKXXAVAYJFCZRJ-UHFFFAOYSA-N 3-methoxy-4-[(7h-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC(O)=CC=C1CNC1=NC=NC2=C1NC=N2 KKXXAVAYJFCZRJ-UHFFFAOYSA-N 0.000 claims 1
- HTAWXNNPZKFZHD-UHFFFAOYSA-N 4-[(7h-purin-6-ylamino)methyl]benzaldehyde Chemical compound C1=CC(C=O)=CC=C1CNC1=NC=NC2=C1NC=N2 HTAWXNNPZKFZHD-UHFFFAOYSA-N 0.000 claims 1
- CUWHREYVNJDAAD-UHFFFAOYSA-N 4-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=CC(O)=CC=C1CNC1=NC=NC2=C1NC=N2 CUWHREYVNJDAAD-UHFFFAOYSA-N 0.000 claims 1
- VRXDOOJUONBFAW-UHFFFAOYSA-N 4-[(7h-purin-6-ylamino)methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CNC1=NC=NC2=C1NC=N2 VRXDOOJUONBFAW-UHFFFAOYSA-N 0.000 claims 1
- JUMUKUPINZJIRV-UHFFFAOYSA-N 4-bromo-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=CC=C(Br)C(O)=C1CNC1=NC=NC2=C1NC=N2 JUMUKUPINZJIRV-UHFFFAOYSA-N 0.000 claims 1
- RBVDVDAIDXFXJS-UHFFFAOYSA-N 4-chloro-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diamine Chemical compound NC1=CC=C(Cl)C(N)=C1CNC1=NC=NC2=C1NC=N2 RBVDVDAIDXFXJS-UHFFFAOYSA-N 0.000 claims 1
- CJYDOBXVUQCFHO-UHFFFAOYSA-N 4-chloro-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC=C(Cl)C=C1CNC1=NC=NC2=C1NC=N2 CJYDOBXVUQCFHO-UHFFFAOYSA-N 0.000 claims 1
- GDVSMPFFKPPMIT-UHFFFAOYSA-N 4-fluoro-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC=C(F)C=C1CNC1=NC=NC2=C1NC=N2 GDVSMPFFKPPMIT-UHFFFAOYSA-N 0.000 claims 1
- LWUMHUDWIBNLGB-UHFFFAOYSA-N 4-methoxy-3-[(7H-purin-6-ylamino)methyl]benzene-1,2-diol Chemical compound COC1=CC=C(O)C(O)=C1CNC1=NC=NC2=C1NC=N2 LWUMHUDWIBNLGB-UHFFFAOYSA-N 0.000 claims 1
- DRQVHTWVNLHDPO-UHFFFAOYSA-N 4-methyl-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound CC1=CC=C(O)C(CNC=2C=3NC=NC=3N=CN=2)=C1 DRQVHTWVNLHDPO-UHFFFAOYSA-N 0.000 claims 1
- PMSMUTAVGRJBBZ-UHFFFAOYSA-N 5-chloro-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diamine Chemical compound NC1=CC(Cl)=CC(N)=C1CNC1=NC=NC2=C1NC=N2 PMSMUTAVGRJBBZ-UHFFFAOYSA-N 0.000 claims 1
- ALKCAYWPVLLGKV-UHFFFAOYSA-N 5-chloro-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC(Cl)=CC=C1CNC1=NC=NC2=C1NC=N2 ALKCAYWPVLLGKV-UHFFFAOYSA-N 0.000 claims 1
- IDVGMCQJTUQFGU-UHFFFAOYSA-N 5-methoxy-4-[(7H-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound COC1=CC(O)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 IDVGMCQJTUQFGU-UHFFFAOYSA-N 0.000 claims 1
- TULBWIJWVPUAFZ-UHFFFAOYSA-N C1=C(OC)C(OC)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 Chemical compound C1=C(OC)C(OC)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 TULBWIJWVPUAFZ-UHFFFAOYSA-N 0.000 claims 1
- CSAWQTZMHDUIQT-UHFFFAOYSA-N [2-acetyloxy-4-[(7h-purin-6-ylamino)methyl]phenyl] acetate Chemical compound C1=C(OC(C)=O)C(OC(=O)C)=CC=C1CNC1=NC=NC2=C1NC=N2 CSAWQTZMHDUIQT-UHFFFAOYSA-N 0.000 claims 1
- KGOJADILROKNMF-UHFFFAOYSA-N [3-[(7h-purin-6-ylamino)methyl]phenyl] acetate Chemical compound CC(=O)OC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 KGOJADILROKNMF-UHFFFAOYSA-N 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 1
- HQRMRQVDUGNACZ-UHFFFAOYSA-N n-[(2,3,4-trichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=C(Cl)C(Cl)=CC=C1CNC1=NC=NC2=C1NC=N2 HQRMRQVDUGNACZ-UHFFFAOYSA-N 0.000 claims 1
- KOJZECVVTJQLNG-UHFFFAOYSA-N n-[(2,3-dichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1Cl KOJZECVVTJQLNG-UHFFFAOYSA-N 0.000 claims 1
- AVABYJXKHLOFKV-UHFFFAOYSA-N n-[(2,4-dichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC(Cl)=CC=C1CNC1=NC=NC2=C1NC=N2 AVABYJXKHLOFKV-UHFFFAOYSA-N 0.000 claims 1
- BUSZAVZMOKMTQL-UHFFFAOYSA-N n-[(2,4-difluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC(F)=CC=C1CNC1=NC=NC2=C1NC=N2 BUSZAVZMOKMTQL-UHFFFAOYSA-N 0.000 claims 1
- YKOPIHVRMLXYAK-UHFFFAOYSA-N n-[(2,4-dimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 YKOPIHVRMLXYAK-UHFFFAOYSA-N 0.000 claims 1
- KYYXCAMBKPJWJZ-UHFFFAOYSA-N n-[(2,4-dimethylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC(C)=CC=C1CNC1=NC=NC2=C1NC=N2 KYYXCAMBKPJWJZ-UHFFFAOYSA-N 0.000 claims 1
- JDNPKVBUQDGGIY-UHFFFAOYSA-N n-[(2,6-dichlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC=CC(Cl)=C1CNC1=NC=NC2=C1NC=N2 JDNPKVBUQDGGIY-UHFFFAOYSA-N 0.000 claims 1
- VBLPENDQWKWZQW-UHFFFAOYSA-N n-[(2-amino-3-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC=C([N+]([O-])=O)C(N)=C1CNC1=NC=NC2=C1NC=N2 VBLPENDQWKWZQW-UHFFFAOYSA-N 0.000 claims 1
- FDPQLKXDSRZCNO-UHFFFAOYSA-N n-[(2-amino-5-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=CC=C(Cl)C=C1CNC1=NC=NC2=C1NC=N2 FDPQLKXDSRZCNO-UHFFFAOYSA-N 0.000 claims 1
- PCAONZPQWOVSQA-UHFFFAOYSA-N n-[(2-chloro-3,4-dimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 PCAONZPQWOVSQA-UHFFFAOYSA-N 0.000 claims 1
- YDUXHAUWLJNLBA-UHFFFAOYSA-N n-[(2-chloro-6-methylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=CC(Cl)=C1CNC1=NC=NC2=C1NC=N2 YDUXHAUWLJNLBA-UHFFFAOYSA-N 0.000 claims 1
- UGNHBTDGSONRKB-UHFFFAOYSA-N n-[(2-methylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 UGNHBTDGSONRKB-UHFFFAOYSA-N 0.000 claims 1
- CBHRFVHKMMMKPW-UHFFFAOYSA-N n-[(3,5-dimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 CBHRFVHKMMMKPW-UHFFFAOYSA-N 0.000 claims 1
- RPNKOEXWIHABLY-UHFFFAOYSA-N n-[(3-amino-4-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(N)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 RPNKOEXWIHABLY-UHFFFAOYSA-N 0.000 claims 1
- XTIXCIICDCEXRA-UHFFFAOYSA-N n-[(3-chloro-2-methylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=C(Cl)C=CC=C1CNC1=NC=NC2=C1NC=N2 XTIXCIICDCEXRA-UHFFFAOYSA-N 0.000 claims 1
- FXGQGYBMZKLBKX-UHFFFAOYSA-N n-[(3-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 FXGQGYBMZKLBKX-UHFFFAOYSA-N 0.000 claims 1
- MWGPOUAZJSTKMG-UHFFFAOYSA-N n-[(3-ethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound CCOC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 MWGPOUAZJSTKMG-UHFFFAOYSA-N 0.000 claims 1
- JLFVTVWYTKYYPS-UHFFFAOYSA-N n-[(3-methoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 JLFVTVWYTKYYPS-UHFFFAOYSA-N 0.000 claims 1
- ZEVSJYYUMBNFIJ-UHFFFAOYSA-N n-[(3-methyl-4-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C([N+]([O-])=O)C(C)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 ZEVSJYYUMBNFIJ-UHFFFAOYSA-N 0.000 claims 1
- MYUNLWWUYPBYDX-UHFFFAOYSA-N n-[(4,5-dimethoxy-2-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(OC)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1[N+]([O-])=O MYUNLWWUYPBYDX-UHFFFAOYSA-N 0.000 claims 1
- XLXYPZRYKVLUAT-UHFFFAOYSA-N n-[(4-amino-3-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C([N+]([O-])=O)C(N)=CC=C1CNC1=NC=NC2=C1NC=N2 XLXYPZRYKVLUAT-UHFFFAOYSA-N 0.000 claims 1
- VPWIBMHNTSAHED-UHFFFAOYSA-N n-[(4-aminophenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(N)=CC=C1CNC1=NC=NC2=C1NC=N2 VPWIBMHNTSAHED-UHFFFAOYSA-N 0.000 claims 1
- CEMZXBDIVIZYGO-UHFFFAOYSA-N n-[(4-chloro-3-nitrophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 CEMZXBDIVIZYGO-UHFFFAOYSA-N 0.000 claims 1
- IMCKTRMLOFTCMD-UHFFFAOYSA-N n-[(4-ethylphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(CC)=CC=C1CNC1=NC=NC2=C1NC=N2 IMCKTRMLOFTCMD-UHFFFAOYSA-N 0.000 claims 1
- RUBMHRLVXWIFOJ-UHFFFAOYSA-N n-[(4-fluoro-3-methylphenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(F)C(C)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 RUBMHRLVXWIFOJ-UHFFFAOYSA-N 0.000 claims 1
- RTDOAIHBIBHEJA-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(F)=CC=C1CNC1=NC=NC2=C1NC=N2 RTDOAIHBIBHEJA-UHFFFAOYSA-N 0.000 claims 1
- JNRWSGYVASKILI-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 JNRWSGYVASKILI-UHFFFAOYSA-N 0.000 claims 1
- XHIXZHUDOCLAGS-UHFFFAOYSA-N n-[(4-octylphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(CCCCCCCC)=CC=C1CNC1=NC=NC2=C1NC=N2 XHIXZHUDOCLAGS-UHFFFAOYSA-N 0.000 claims 1
- LZDVRUUXMXOFHS-UHFFFAOYSA-N n-[(4-pentoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(OCCCCC)=CC=C1CNC1=NC=NC2=C1NC=N2 LZDVRUUXMXOFHS-UHFFFAOYSA-N 0.000 claims 1
- ZDLYZCJJYVOLAA-UHFFFAOYSA-N n-[(4-phenylphenyl)methyl]-7h-purin-6-amine Chemical compound N=1C=NC=2N=CNC=2C=1NCC(C=C1)=CC=C1C1=CC=CC=C1 ZDLYZCJJYVOLAA-UHFFFAOYSA-N 0.000 claims 1
- FKAKDTIRJDGFQR-UHFFFAOYSA-N n-[(4-propoxyphenyl)methyl]-7h-purin-6-amine Chemical compound C1=CC(OCCC)=CC=C1CNC1=NC=NC2=C1NC=N2 FKAKDTIRJDGFQR-UHFFFAOYSA-N 0.000 claims 1
- HQYLLFYWLITPQP-UHFFFAOYSA-N n-[(5-chloro-2-methoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC=C(Cl)C=C1CNC1=NC=NC2=C1NC=N2 HQYLLFYWLITPQP-UHFFFAOYSA-N 0.000 claims 1
- MJCCCYVXECJQLT-UHFFFAOYSA-N n-[(5-fluoro-2-methylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=C(F)C=C1CNC1=NC=NC2=C1NC=N2 MJCCCYVXECJQLT-UHFFFAOYSA-N 0.000 claims 1
- RPBYPBLFEKQBJV-UHFFFAOYSA-N n-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC1=CC(C(F)(F)F)=CC=C1CNC1=NC=NC2=C1NC=N2 RPBYPBLFEKQBJV-UHFFFAOYSA-N 0.000 claims 1
- ZFYPUAIDDCUKPQ-UHFFFAOYSA-N n-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC1=CC=CC(C(F)(F)F)=C1CNC1=NC=NC2=C1NC=N2 ZFYPUAIDDCUKPQ-UHFFFAOYSA-N 0.000 claims 1
- MHPOLRCURAIMEF-UHFFFAOYSA-N n-[[3-(difluoromethoxy)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)OC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 MHPOLRCURAIMEF-UHFFFAOYSA-N 0.000 claims 1
- OGHCQJVDECKMJZ-UHFFFAOYSA-N n-[[4-(diethylamino)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC(N(CC)CC)=CC=C1CNC1=NC=NC2=C1NC=N2 OGHCQJVDECKMJZ-UHFFFAOYSA-N 0.000 claims 1
- ZHQMFDHQGVOYDP-UHFFFAOYSA-N n-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 ZHQMFDHQGVOYDP-UHFFFAOYSA-N 0.000 claims 1
- LUZZCKBEQKUNEI-UHFFFAOYSA-N n-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1CNC1=NC=NC2=C1NC=N2 LUZZCKBEQKUNEI-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 description 47
- 239000004062 cytokinin Substances 0.000 description 37
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 239000004480 active ingredient Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- 241000196324 Embryophyta Species 0.000 description 19
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 239000002609 medium Substances 0.000 description 18
- 238000011534 incubation Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 229920003266 Leaf® Polymers 0.000 description 14
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 210000004698 lymphocyte Anatomy 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 229920001223 polyethylene glycol Chemical class 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 239000002775 capsule Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 241000209140 Triticum Species 0.000 description 9
- 235000021307 Triticum Nutrition 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 239000001828 Gelatine Substances 0.000 description 8
- 239000002202 Polyethylene glycol Chemical class 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 229920000159 gelatin Polymers 0.000 description 8
- 235000019322 gelatine Nutrition 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 102000005133 Glutamate 5-kinase Human genes 0.000 description 6
- 108700023479 Glutamate 5-kinases Proteins 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 230000006907 apoptotic process Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229930002875 chlorophyll Natural products 0.000 description 6
- 235000019804 chlorophyll Nutrition 0.000 description 6
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 230000001506 immunosuppresive effect Effects 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 6
- XHRJGHCQQPETRH-KQYNXXCUSA-N (2r,3r,4s,5r)-2-(6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(Cl)=C2N=C1 XHRJGHCQQPETRH-KQYNXXCUSA-N 0.000 description 5
- CHADEQDQBURGHL-UHFFFAOYSA-N (6'-acetyloxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(OC(C)=O)C=C1OC1=CC(OC(=O)C)=CC=C21 CHADEQDQBURGHL-UHFFFAOYSA-N 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 5
- 244000061176 Nicotiana tabacum Species 0.000 description 5
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- OJHAHQJRQIOCFK-UHFFFAOYSA-N azane;chloroform;methanol Chemical compound N.OC.ClC(Cl)Cl OJHAHQJRQIOCFK-UHFFFAOYSA-N 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 229910002091 carbon monoxide Inorganic materials 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- 102000011727 Caspases Human genes 0.000 description 4
- 108010076667 Caspases Proteins 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- 239000005662 Paraffin oil Substances 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000022131 cell cycle Effects 0.000 description 4
- 230000030833 cell death Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 229940093499 ethyl acetate Drugs 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- 125000005456 glyceride group Chemical group 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- BUDWTFCZGZYQHZ-UHFFFAOYSA-N meta-topolin Natural products OC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 BUDWTFCZGZYQHZ-UHFFFAOYSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N pentadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical class NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 108090000397 Caspase 3 Proteins 0.000 description 3
- 102100029855 Caspase-3 Human genes 0.000 description 3
- 102000004039 Caspase-9 Human genes 0.000 description 3
- 108090000566 Caspase-9 Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 235000011449 Rosa Nutrition 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000001640 apoptogenic effect Effects 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 238000004166 bioassay Methods 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 150000002334 glycols Chemical class 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 229960000367 inositol Drugs 0.000 description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 239000003226 mitogen Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 229910052762 osmium Inorganic materials 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- GRRIMVWABNHKBX-UHFFFAOYSA-N (3-methoxyphenyl)methanamine Chemical compound COC1=CC=CC(CN)=C1 GRRIMVWABNHKBX-UHFFFAOYSA-N 0.000 description 2
- ALZSTTDFHZHSCA-RNVDEAKXSA-N (4s)-4-[[(2s)-2-acetamido-3-carboxypropanoyl]amino]-5-[[(2s)-1-[[(2s)-3-carboxy-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC1=CC(=O)OC2=CC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(C)=O)C(C)C)=CC=C21 ALZSTTDFHZHSCA-RNVDEAKXSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WYOHUQDZZVVATD-UHFFFAOYSA-N 2-[(7h-purin-6-ylamino)methyl]benzene-1,3,5-triol Chemical compound OC1=CC(O)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 WYOHUQDZZVVATD-UHFFFAOYSA-N 0.000 description 2
- OIQOAYVCKAHSEJ-UHFFFAOYSA-N 2-[2,3-bis(2-hydroxyethoxy)propoxy]ethanol;hexadecanoic acid;octadecanoic acid Chemical compound OCCOCC(OCCO)COCCO.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O OIQOAYVCKAHSEJ-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 108010021160 Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000219318 Amaranthus Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229940123169 Caspase inhibitor Drugs 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- XXFACTAYGKKOQB-SSDOTTSWSA-N Dihydrozeatin Natural products OC[C@H](C)CCNC1=NC=NC2=C1NC=N2 XXFACTAYGKKOQB-SSDOTTSWSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- HYVABZIGRDEKCD-UHFFFAOYSA-N N(6)-dimethylallyladenine Chemical compound CC(C)=CCNC1=NC=NC2=C1N=CN2 HYVABZIGRDEKCD-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 244000154511 Rosa hybrid cultivar Species 0.000 description 2
- 235000002315 Rosa hybrid cultivar Nutrition 0.000 description 2
- 244000050053 Rosa multiflora Species 0.000 description 2
- 235000000656 Rosa multiflora Nutrition 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 241000109329 Rosa xanthina Species 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- MIFGOLAMNLSLGH-QOKNQOGYSA-N Z-Val-Ala-Asp(OMe)-CH2F Chemical compound COC(=O)C[C@@H](C(=O)CF)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1 MIFGOLAMNLSLGH-QOKNQOGYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 239000003121 adenosine kinase inhibitor Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000006136 alcoholysis reaction Methods 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000000842 betacyanins Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- DIKBFYAXUHHXCS-UHFFFAOYSA-N bromoform Chemical compound BrC(Br)Br DIKBFYAXUHHXCS-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 230000006882 induction of apoptosis Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000009456 molecular mechanism Effects 0.000 description 2
- QTHDKRDGRLYUAG-UHFFFAOYSA-N n-[(2-chloro-3,6-difluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC=C(F)C(CNC=2C=3NC=NC=3N=CN=2)=C1Cl QTHDKRDGRLYUAG-UHFFFAOYSA-N 0.000 description 2
- DKNZIMSMXKMGDM-UHFFFAOYSA-N n-[(3-chloro-4-fluorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(F)=CC=C1CNC1=NC=NC2=C1NC=N2 DKNZIMSMXKMGDM-UHFFFAOYSA-N 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000009696 proliferative response Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- MKWYFZFMAMBPQK-UHFFFAOYSA-J sodium feredetate Chemical compound [Na+].[Fe+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O MKWYFZFMAMBPQK-UHFFFAOYSA-J 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000002511 suppository base Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940100445 wheat starch Drugs 0.000 description 2
- 229940023877 zeatin Drugs 0.000 description 2
- HJXWZGVMHDPCRS-UUOKFMHZSA-N (2r,3r,4s,5r)-2-(2,6-dichloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC(Cl)=NC(Cl)=C2N=C1 HJXWZGVMHDPCRS-UUOKFMHZSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- RGXUCUWVGKLACF-UHFFFAOYSA-N (3-methylphenyl)methanamine Chemical compound CC1=CC=CC(CN)=C1 RGXUCUWVGKLACF-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-OFKYTIFKSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(tritiooxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](CO[3H])O[C@H]1N1C(=O)NC(=O)C(C)=C1 IQFYYKKMVGJFEH-OFKYTIFKSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- RZXXUHNBYMMPBG-UHFFFAOYSA-N 2,3,4-trimethoxy-6-[(7H-purin-6-ylamino)methyl]phenol Chemical compound COC1=C(OC)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O RZXXUHNBYMMPBG-UHFFFAOYSA-N 0.000 description 1
- JUWUVFVYQRRVHS-UHFFFAOYSA-N 2,4-dimethoxy-3-[(7H-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC=C(O)C(OC)=C1CNC1=NC=NC2=C1NC=N2 JUWUVFVYQRRVHS-UHFFFAOYSA-N 0.000 description 1
- KSOIDURHJOLERS-UHFFFAOYSA-N 2,4-dimethoxy-5-[(7h-purin-6-ylamino)methyl]phenol Chemical compound C1=C(O)C(OC)=CC(OC)=C1CNC1=NC=NC2=C1NC=N2 KSOIDURHJOLERS-UHFFFAOYSA-N 0.000 description 1
- HHJOKRDRPDKQEN-UHFFFAOYSA-N 2,5-dimethoxy-3-[(7H-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC(O)=C(OC)C(CNC=2C=3NC=NC=3N=CN=2)=C1 HHJOKRDRPDKQEN-UHFFFAOYSA-N 0.000 description 1
- BEDVMCZXUOLIRE-UHFFFAOYSA-N 2,6-dimethoxy-4-[(7h-purin-6-ylamino)methyl]phenol Chemical compound COC1=C(O)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 BEDVMCZXUOLIRE-UHFFFAOYSA-N 0.000 description 1
- CLJHZQFAKIIMBA-UHFFFAOYSA-N 2-(aminomethyl)-6-methoxyphenol Chemical compound COC1=CC=CC(CN)=C1O CLJHZQFAKIIMBA-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- FUULCYMSCDDKNZ-UHFFFAOYSA-N 2-chloro-n-[(3-methoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC=CC(CNC=2C=3NC=NC=3N=C(Cl)N=2)=C1 FUULCYMSCDDKNZ-UHFFFAOYSA-N 0.000 description 1
- QLPKAOLYBUZZLY-UHFFFAOYSA-N 2-methoxy-6-[(7h-purin-6-ylamino)methyl]benzene-1,4-diol Chemical compound COC1=CC(O)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O QLPKAOLYBUZZLY-UHFFFAOYSA-N 0.000 description 1
- LYHDZSQXAKLVHV-UHFFFAOYSA-N 2-methyl-6-[(7h-purin-6-ylamino)methyl]phenol Chemical compound CC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O LYHDZSQXAKLVHV-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ITJSCCSRJGFJDO-UHFFFAOYSA-N 3,6-dimethoxy-2-[(7H-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC=C(OC)C(CNC=2C=3NC=NC=3N=CN=2)=C1O ITJSCCSRJGFJDO-UHFFFAOYSA-N 0.000 description 1
- RRBLNIWSKIFFQL-UHFFFAOYSA-N 3-(aminomethyl)benzene-1,2-diol;hydrobromide Chemical compound Br.NCC1=CC=CC(O)=C1O RRBLNIWSKIFFQL-UHFFFAOYSA-N 0.000 description 1
- GCMFHRBJECJDHE-UHFFFAOYSA-N 3-chloro-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC=CC(Cl)=C1CNC1=NC=NC2=C1NC=N2 GCMFHRBJECJDHE-UHFFFAOYSA-N 0.000 description 1
- BRNFSOIOUTVDNV-UHFFFAOYSA-N 3-chloro-6-[(7h-purin-6-ylamino)methyl]benzene-1,2-diol Chemical compound OC1=C(Cl)C=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O BRNFSOIOUTVDNV-UHFFFAOYSA-N 0.000 description 1
- AFBRDHJTCWMHCK-UHFFFAOYSA-N 3-fluoro-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC=CC(F)=C1CNC1=NC=NC2=C1NC=N2 AFBRDHJTCWMHCK-UHFFFAOYSA-N 0.000 description 1
- MOZLBBUYZKNEDS-UHFFFAOYSA-N 3-fluoro-4-[(7h-purin-6-ylamino)methyl]phenol Chemical compound FC1=CC(O)=CC=C1CNC1=NC=NC2=C1NC=N2 MOZLBBUYZKNEDS-UHFFFAOYSA-N 0.000 description 1
- HNVORJSATMLPQV-UHFFFAOYSA-N 3-methoxy-6-[(7h-purin-6-ylamino)methyl]benzene-1,2-diol Chemical compound OC1=C(O)C(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 HNVORJSATMLPQV-UHFFFAOYSA-N 0.000 description 1
- GEYNZDRQJBSZTJ-UHFFFAOYSA-N 4,6-difluoro-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=C(F)C=C(F)C(O)=C1CNC1=NC=NC2=C1NC=N2 GEYNZDRQJBSZTJ-UHFFFAOYSA-N 0.000 description 1
- OQYDHOINOLLZLM-UHFFFAOYSA-N 4,6-diiodo-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=C(I)C=C(I)C(O)=C1CNC1=NC=NC2=C1NC=N2 OQYDHOINOLLZLM-UHFFFAOYSA-N 0.000 description 1
- HTWSSFHOAPVIKR-UHFFFAOYSA-N 4-bromo-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC=C(Br)C=C1CNC1=NC=NC2=C1NC=N2 HTWSSFHOAPVIKR-UHFFFAOYSA-N 0.000 description 1
- AMARHPHEVUGDIQ-UHFFFAOYSA-N 4-chloro-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=CC=C(Cl)C(O)=C1CNC1=NC=NC2=C1NC=N2 AMARHPHEVUGDIQ-UHFFFAOYSA-N 0.000 description 1
- CDTPBLDWGQHOBC-UHFFFAOYSA-N 4-fluoro-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=CC=C(F)C(O)=C1CNC1=NC=NC2=C1NC=N2 CDTPBLDWGQHOBC-UHFFFAOYSA-N 0.000 description 1
- JMFJDXSAKDVXCB-UHFFFAOYSA-N 4-iodo-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=CC=C(I)C(O)=C1CNC1=NC=NC2=C1NC=N2 JMFJDXSAKDVXCB-UHFFFAOYSA-N 0.000 description 1
- XOTMXHPHPFZHHN-UHFFFAOYSA-N 4-methoxy-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound COC1=CC=C(O)C(CNC=2C=3NC=NC=3N=CN=2)=C1 XOTMXHPHPFZHHN-UHFFFAOYSA-N 0.000 description 1
- WLMSUVDJCVNFRS-UHFFFAOYSA-N 4-methoxy-5-[(7H-purin-6-ylamino)methyl]benzene-1,2-diol Chemical compound COC1=CC(O)=C(O)C=C1CNC1=NC=NC2=C1NC=N2 WLMSUVDJCVNFRS-UHFFFAOYSA-N 0.000 description 1
- RZRGHLSEWBKKFM-UHFFFAOYSA-N 4-methoxy-6-[(7H-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound C1=C(O)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O RZRGHLSEWBKKFM-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- ZENFIPDFEFLRBR-UHFFFAOYSA-N 5-fluoro-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC(F)=CC=C1CNC1=NC=NC2=C1NC=N2 ZENFIPDFEFLRBR-UHFFFAOYSA-N 0.000 description 1
- HSHXDLULSPXYFI-UHFFFAOYSA-N 5-iodo-2-[(7h-purin-6-ylamino)methyl]benzene-1,3-diol Chemical compound OC1=CC(I)=CC(O)=C1CNC1=NC=NC2=C1NC=N2 HSHXDLULSPXYFI-UHFFFAOYSA-N 0.000 description 1
- KUZWSUZOOREBKZ-UHFFFAOYSA-N 5-iodo-2-[(7h-purin-6-ylamino)methyl]phenol Chemical compound OC1=CC(I)=CC=C1CNC1=NC=NC2=C1NC=N2 KUZWSUZOOREBKZ-UHFFFAOYSA-N 0.000 description 1
- QZETWFFTPCZUMJ-UHFFFAOYSA-N 6-chloro-2-methylsulfanyl-7h-purine Chemical compound CSC1=NC(Cl)=C2NC=NC2=N1 QZETWFFTPCZUMJ-UHFFFAOYSA-N 0.000 description 1
- RYYIULNRIVUMTQ-UHFFFAOYSA-N 6-chloroguanine Chemical compound NC1=NC(Cl)=C2N=CNC2=N1 RYYIULNRIVUMTQ-UHFFFAOYSA-N 0.000 description 1
- OGMOQXGQNUUPAX-UHFFFAOYSA-N 6-n-[(2-methoxyphenyl)methyl]-7h-purine-2,6-diamine Chemical compound COC1=CC=CC=C1CNC1=NC(N)=NC2=C1NC=N2 OGMOQXGQNUUPAX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GOSWTRUMMSCNCW-HNNGNKQASA-N 9-ribosyl-trans-zeatin Chemical compound C1=NC=2C(NC\C=C(CO)/C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O GOSWTRUMMSCNCW-HNNGNKQASA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 241000711313 Athesis Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 108091007914 CDKs Proteins 0.000 description 1
- ZYEZBVIRQBPXGV-UHFFFAOYSA-N COC1=C(O)C=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O Chemical compound COC1=C(O)C=CC(CNC=2C=3NC=NC=3N=CN=2)=C1O ZYEZBVIRQBPXGV-UHFFFAOYSA-N 0.000 description 1
- VLZYAZJLDIUGKX-UHFFFAOYSA-N COC1=CC(O)=C(O)C(CNC=2C=3NC=NC=3N=CN=2)=C1 Chemical compound COC1=CC(O)=C(O)C(CNC=2C=3NC=NC=3N=CN=2)=C1 VLZYAZJLDIUGKX-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241001649081 Dina Species 0.000 description 1
- MWRWFPQBGSZWNV-UHFFFAOYSA-N Dinitrosopentamethylenetetramine Chemical compound C1N2CN(N=O)CN1CN(N=O)C2 MWRWFPQBGSZWNV-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241001061260 Emmelichthys struhsakeri Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 208000036566 Erythroleukaemia Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WQZGKKKJIJFFOK-ZNVMLXAYSA-N L-idopyranose Chemical group OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-ZNVMLXAYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- OMAQRYFQDNAMPC-UHFFFAOYSA-N N-[(2-chloro-6-fluoro-3-methylphenyl)methyl]-7H-purin-6-amine 7H-purine Chemical compound N1=CN=C2N=CNC2=C1.ClC1=C(CNC2=C3NC=NC3=NC=N2)C(=CC=C1C)F OMAQRYFQDNAMPC-UHFFFAOYSA-N 0.000 description 1
- XTPMQHVMJMATML-UHFFFAOYSA-N N-[(3-methylphenyl)methyl]-2-methylsulfanyl-7H-purin-6-amine Chemical compound C=12NC=NC2=NC(SC)=NC=1NCC1=CC=CC(C)=C1 XTPMQHVMJMATML-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- ABXOYXLLWUTEQZ-UHFFFAOYSA-N OC1=C(OC)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 Chemical compound OC1=C(OC)C(OC)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 ABXOYXLLWUTEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000133018 Panax trifolius Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 244000180577 Sambucus australis Species 0.000 description 1
- 235000018734 Sambucus australis Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- FNYLWPVRPXGIIP-UHFFFAOYSA-N Triamterene Chemical compound NC1=NC2=NC(N)=NC(N)=C2N=C1C1=CC=CC=C1 FNYLWPVRPXGIIP-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 108010051847 acetyl-leucyl-glutamyl-histidyl-aspartyl-7-amino-4-methylcoumarin Proteins 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000003939 benzylamines Chemical class 0.000 description 1
- 230000001774 betacyanin synthesis Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000011138 biotechnological process Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 229950005228 bromoform Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- FAPWYRCQGJNNSJ-CTWWJBIBSA-L calcium;3-[[(2s)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate Chemical compound [Ca+2].OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-CTWWJBIBSA-L 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000035572 chemosensitivity Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- UMNKXPULIDJLSU-UHFFFAOYSA-N dichlorofluoromethane Chemical compound FC(Cl)Cl UMNKXPULIDJLSU-UHFFFAOYSA-N 0.000 description 1
- 229940099364 dichlorofluoromethane Drugs 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- XXFACTAYGKKOQB-ZETCQYMHSA-N dihydrozeatin Chemical compound OC[C@@H](C)CCNC1=NC=NC2=C1NC=N2 XXFACTAYGKKOQB-ZETCQYMHSA-N 0.000 description 1
- LLRANSBEYQZKFY-UHFFFAOYSA-N dodecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCC(O)=O LLRANSBEYQZKFY-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000012137 double-staining Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000008124 floral development Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000005078 fruit development Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- VRWKTAYJTKRVCU-UHFFFAOYSA-N iron(6+);hexacyanide Chemical compound [Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] VRWKTAYJTKRVCU-UHFFFAOYSA-N 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- 238000007392 microtiter assay Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- QJELRIITWZBZPR-UHFFFAOYSA-N n-[(2,3,4-trimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=C(OC)C(OC)=CC=C1CNC1=NC=NC2=C1NC=N2 QJELRIITWZBZPR-UHFFFAOYSA-N 0.000 description 1
- NTASOVFAINMBAX-UHFFFAOYSA-N n-[(2,3-difluoro-4-methylphenyl)methyl]-7h-purin-6-amine Chemical compound FC1=C(F)C(C)=CC=C1CNC1=NC=NC2=C1NC=N2 NTASOVFAINMBAX-UHFFFAOYSA-N 0.000 description 1
- LQADMUZAFXDMQU-UHFFFAOYSA-N n-[(2,4,5-trimethoxyphenyl)methyl]-7h-purin-6-amine Chemical compound COC1=CC(OC)=C(OC)C=C1CNC1=NC=NC2=C1NC=N2 LQADMUZAFXDMQU-UHFFFAOYSA-N 0.000 description 1
- SVIMLTIDAORYBV-UHFFFAOYSA-N n-[(2,5-difluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC=C(F)C(CNC=2C=3NC=NC=3N=CN=2)=C1 SVIMLTIDAORYBV-UHFFFAOYSA-N 0.000 description 1
- ICPDUPRJBVCERA-UHFFFAOYSA-N n-[(2,6-difluoro-3-methylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=C(F)C(CNC=2C=3NC=NC=3N=CN=2)=C1F ICPDUPRJBVCERA-UHFFFAOYSA-N 0.000 description 1
- UTXLKRLLDKYDLO-UHFFFAOYSA-N n-[(2,6-dimethylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=CC(C)=C1CNC1=NC=NC2=C1NC=N2 UTXLKRLLDKYDLO-UHFFFAOYSA-N 0.000 description 1
- MQUMZCFRTNEZBT-UHFFFAOYSA-N n-[(2-amino-4-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=CC(Cl)=CC=C1CNC1=NC=NC2=C1NC=N2 MQUMZCFRTNEZBT-UHFFFAOYSA-N 0.000 description 1
- JOKWOTYVMPTGJL-UHFFFAOYSA-N n-[(2-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound ClC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 JOKWOTYVMPTGJL-UHFFFAOYSA-N 0.000 description 1
- ZDOQFEFKZILKMM-UHFFFAOYSA-N n-[(2-fluorophenyl)methyl]-7h-purin-6-amine Chemical compound FC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 ZDOQFEFKZILKMM-UHFFFAOYSA-N 0.000 description 1
- XGHCPUYMXPYVHA-UHFFFAOYSA-N n-[(3,4-difluorophenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(F)C(F)=CC=C1CNC1=NC=NC2=C1NC=N2 XGHCPUYMXPYVHA-UHFFFAOYSA-N 0.000 description 1
- BWNIFZRGYKHWNF-UHFFFAOYSA-N n-[(3-amino-2-chlorophenyl)methyl]-7h-purin-6-amine Chemical compound NC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1Cl BWNIFZRGYKHWNF-UHFFFAOYSA-N 0.000 description 1
- FKSQJVJXEFKZQE-UHFFFAOYSA-N n-[(3-bromophenyl)methyl]-7h-purin-6-amine Chemical compound BrC1=CC=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 FKSQJVJXEFKZQE-UHFFFAOYSA-N 0.000 description 1
- XWTPVBIJZHZHBA-UHFFFAOYSA-N n-[(3-chloro-4-methylphenyl)methyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(C)=CC=C1CNC1=NC=NC2=C1NC=N2 XWTPVBIJZHZHBA-UHFFFAOYSA-N 0.000 description 1
- ZQXNZVHFFJPEIV-UHFFFAOYSA-N n-[(6-chloro-2-fluoro-3-methylphenyl)methyl]-7h-purin-6-amine Chemical compound CC1=CC=C(Cl)C(CNC=2C=3NC=NC=3N=CN=2)=C1F ZQXNZVHFFJPEIV-UHFFFAOYSA-N 0.000 description 1
- YTXLDHSIQKYHKB-UHFFFAOYSA-N n-[[2-(difluoromethoxy)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)OC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 YTXLDHSIQKYHKB-UHFFFAOYSA-N 0.000 description 1
- WEVDRICHXYEAKR-UHFFFAOYSA-N n-[[2-(trifluoromethoxy)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)(F)OC1=CC=CC=C1CNC1=NC=NC2=C1NC=N2 WEVDRICHXYEAKR-UHFFFAOYSA-N 0.000 description 1
- LMJWSMCQEHVOJX-UHFFFAOYSA-N n-[[3-chloro-2-fluoro-5-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC1=C(Cl)C=C(C(F)(F)F)C=C1CNC1=NC=NC2=C1NC=N2 LMJWSMCQEHVOJX-UHFFFAOYSA-N 0.000 description 1
- MOBCTZQTORSRRJ-UHFFFAOYSA-N n-[[3-chloro-2-fluoro-6-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC1=C(Cl)C=CC(C(F)(F)F)=C1CNC1=NC=NC2=C1NC=N2 MOBCTZQTORSRRJ-UHFFFAOYSA-N 0.000 description 1
- JUPNSPXFJLCVNL-UHFFFAOYSA-N n-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC(F)(F)C1=CC(F)=CC(CNC=2C=3NC=NC=3N=CN=2)=C1 JUPNSPXFJLCVNL-UHFFFAOYSA-N 0.000 description 1
- QPHFEMZEDCBMGG-UHFFFAOYSA-N n-[[4-(bromomethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound C1=CC(CBr)=CC=C1CNC1=NC=NC2=C1NC=N2 QPHFEMZEDCBMGG-UHFFFAOYSA-N 0.000 description 1
- SQARHURQBIBDJB-UHFFFAOYSA-N n-[[5-fluoro-2-(trifluoromethyl)phenyl]methyl]-7h-purin-6-amine Chemical compound FC1=CC=C(C(F)(F)F)C(CNC=2C=3NC=NC=3N=CN=2)=C1 SQARHURQBIBDJB-UHFFFAOYSA-N 0.000 description 1
- CHVZPRDGLWBEMJ-UHFFFAOYSA-N n-chlorobenzenesulfonamide Chemical compound ClNS(=O)(=O)C1=CC=CC=C1 CHVZPRDGLWBEMJ-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960005419 nitrogen Drugs 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000014284 seed dormancy process Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000012622 synthetic inhibitor Substances 0.000 description 1
- 239000002700 tablet coating Substances 0.000 description 1
- 238000009492 tablet coating Methods 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- GOSWTRUMMSCNCW-UHFFFAOYSA-N trans-zeatin riboside Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1OC(CO)C(O)C1O GOSWTRUMMSCNCW-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20024273A CZ294538B6 (cs) | 2002-12-30 | 2002-12-30 | Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200506074B true ZA200506074B (en) | 2006-05-31 |
Family
ID=32661130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200506074A ZA200506074B (en) | 2002-12-30 | 2005-07-28 | Substitution derivatives of N6-benzyladenosine, methods of their preparation, their use for preperation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8119614B2 (cs) |
| EP (1) | EP1575973B1 (cs) |
| AU (1) | AU2003294608A1 (cs) |
| CZ (1) | CZ294538B6 (cs) |
| WO (1) | WO2004058791A2 (cs) |
| ZA (1) | ZA200506074B (cs) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1699459B1 (en) * | 2003-12-29 | 2007-06-06 | Can-Fite Biopharma Ltd. | Method for treatment of multiple sclerosis |
| US20070183995A1 (en) * | 2006-02-09 | 2007-08-09 | Conopco, Inc., D/B/A Unilever | Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same |
| US7351434B2 (en) * | 2006-04-07 | 2008-04-01 | Academia Sinica | Therapeutic Gastrodia extracts |
| US8129357B2 (en) * | 2006-04-07 | 2012-03-06 | Academia Sinica | Method of making and using an adenosine analogue |
| US7893227B2 (en) | 2006-12-05 | 2011-02-22 | Lasergen, Inc. | 3′-OH unblocked nucleotides and nucleosides base modified with non-cleavable, terminating groups and methods for their use in DNA sequencing |
| CN102443030B (zh) * | 2006-12-05 | 2015-12-16 | 激光基因公司 | 光可断裂的标记核苷酸和核苷与标记的核苷酸和核苷以及其在dna测序中的使用方法 |
| US7897737B2 (en) | 2006-12-05 | 2011-03-01 | Lasergen, Inc. | 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing |
| BRPI0915173B8 (pt) | 2008-06-11 | 2021-05-25 | Agilent Technologies Inc | compostos de nucleotídeos e nucleosídeos e método de sequenciamento de um ácido nucleico-alvo |
| US20110237606A1 (en) * | 2008-09-26 | 2011-09-29 | Agency Of Science, Technology And Research | 3-Deazaneplanocin Derivatives |
| CZ2009298A3 (cs) * | 2009-05-14 | 2010-11-24 | Univerzita Palackého v Olomouci | Substituované 6-benzylaminopurin ribosidy, jejich použití a farmaceutický prípravek tyto slouceniny obsahující |
| CN102482278B (zh) | 2009-06-29 | 2015-04-22 | 因塞特公司 | 作为pi3k抑制剂的嘧啶酮类 |
| CZ302618B6 (cs) | 2009-09-10 | 2011-08-03 | Univerzita Palackého | Cyklobutan-1,1-dikarboxylátokomplexy platiny s deriváty N6-benzyladeninu, zpusoby jejich prípravy a použití techto komplexu jako léciv v protinádorové terapii |
| EP2498774B1 (en) * | 2009-11-13 | 2017-10-11 | Academia Sinica | Dual-action compounds targeting adenosine a2a receptor and adenosine transporter for prevention and treatment of neurodegenerative diseases |
| EP2511283A4 (en) * | 2009-12-10 | 2013-07-03 | Inst Materia Medica Cams | N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND THEIR USE |
| US8759359B2 (en) * | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
| TW201130842A (en) * | 2009-12-18 | 2011-09-16 | Incyte Corp | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
| CA2796311A1 (en) | 2010-04-14 | 2011-10-20 | Incyte Corporation | Fused derivatives as pi3k.delta. inhibitors |
| CZ303327B6 (cs) | 2010-04-29 | 2012-08-01 | Univerzita Palackého v Olomouci | Substitucní deriváty N6-benzyladenosin-5´-monofosfátu, zpusoby jejich prípravy, tyto deriváty pro použití jako léciva a terapeutický prípravek je obsahující |
| US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
| EP3660016A1 (en) | 2010-12-20 | 2020-06-03 | Incyte Holdings Corporation | N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors |
| US9493502B2 (en) | 2011-01-26 | 2016-11-15 | Beijing Kbd Pharmaceuticals Co., Ltd. | Ribofuranosyl purine compounds, methods for preparing the same and use thereof |
| CN102617680B (zh) * | 2011-02-01 | 2014-04-02 | 复旦大学 | 一种双功能抗血小板聚集药物及其用途 |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
| SG10201912484RA (en) | 2011-09-02 | 2020-02-27 | Incyte Corp | Heterocyclylamines as pi3k inhibitors |
| CN104024269B (zh) | 2011-09-13 | 2017-05-24 | 激光基因公司 | 5‑甲氧基，3’‑oh未阻断，可快速光切割的终止核苷酸以及用于核酸测序的方法 |
| AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
| CZ306894B6 (cs) | 2013-02-08 | 2017-08-30 | Univerzita PalackĂ©ho v Olomouci | 2-Substituované-6-biarylmethylamino-9-cyklopentyl-9H-purinové deriváty, jejich použití jako léčiva a farmaceutické přípravky tyto sloučeniny obsahující |
| WO2014145386A2 (en) * | 2013-03-15 | 2014-09-18 | University Of Florida Research Foundation Incorporated | Novel allosteric inhibitors of thymidylate synthase |
| WO2015191677A1 (en) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors |
| CZ308881B6 (cs) * | 2014-12-09 | 2021-08-04 | Univerzita Palackého v Olomouci | 6-aryl-9-glykosylpuriny a jejich použití |
| PH12021551128A1 (en) | 2015-02-27 | 2023-06-14 | Incyte Holdings Corp | Salts of pi3k inhibitor and processes for their preparation |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| US10835524B2 (en) | 2015-06-24 | 2020-11-17 | University Of Florida Research Foundation, Incorporated | Compositions for the treatment of pancreatic cancer and uses thereof |
| JP2015172077A (ja) * | 2015-06-24 | 2015-10-01 | 中国医学科学院葯物研究所 | Ｎ６−置換アデノシン誘導体とｎ６−置換アデニン誘導体の鎮静、催眠、抗うつ、抗痙攣、抗てんかん、抗パーキンソン病と認知証予防・治療の用途 |
| CN108329372B (zh) * | 2017-01-20 | 2022-07-26 | 浙江省亚热带作物研究所 | N6-(2-羟乙基)腺苷及其衍生物在制备治疗痛风药物中的应用 |
| CA3101323A1 (en) | 2018-06-01 | 2019-12-05 | Incyte Corporation | Dosing regimen for the treatment of pi3k related disorders |
| WO2022012702A1 (en) | 2020-07-13 | 2022-01-20 | Univerzita Palackeho V Olomouci | Nitrogen heterocyclic cytokinin derivatives, compositions containing these derivatives and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3506643A (en) * | 1966-12-09 | 1970-04-14 | Max Thiel | N**6-aralkyl-adenosine derivatives |
| NL6717061A (cs) * | 1966-12-21 | 1968-06-24 | ||
| DE2007273A1 (de) * | 1970-02-18 | 1971-08-26 | Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof | N(6) Aralkyl adenosin Derivate und Verfahren zur Herstellung derselben |
| DE2059922A1 (de) * | 1970-12-05 | 1972-06-15 | Boehringer Mannheim Gmbh | Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben |
| DE2136624A1 (de) * | 1971-07-22 | 1973-02-08 | Boehringer Mannheim Gmbh | N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben |
| US4514405A (en) * | 1981-09-17 | 1985-04-30 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Use of adenosine derivatives as anticonvulsants |
| AU659861B2 (en) | 1991-09-10 | 1995-06-01 | Sansho Seiyaku Co., Ltd. | Preparation for promoting hair growth |
| AU7331094A (en) * | 1993-07-13 | 1995-02-13 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | A3 adenosine receptor agonists |
-
2002
- 2002-12-30 CZ CZ20024273A patent/CZ294538B6/cs not_active IP Right Cessation
-
2003
- 2003-12-29 EP EP03785482.5A patent/EP1575973B1/en not_active Expired - Lifetime
- 2003-12-29 AU AU2003294608A patent/AU2003294608A1/en not_active Abandoned
- 2003-12-29 WO PCT/CZ2003/000078 patent/WO2004058791A2/en not_active Application Discontinuation
- 2003-12-29 US US10/540,993 patent/US8119614B2/en not_active Expired - Fee Related
-
2005
- 2005-07-28 ZA ZA200506074A patent/ZA200506074B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1575973A2 (en) | 2005-09-21 |
| US20060166925A1 (en) | 2006-07-27 |
| WO2004058791A3 (en) | 2004-10-28 |
| CZ294538B6 (cs) | 2005-01-12 |
| WO2004058791A2 (en) | 2004-07-15 |
| AU2003294608A8 (en) | 2004-07-22 |
| CZ20024273A3 (en) | 2004-08-18 |
| EP1575973B1 (en) | 2017-08-23 |
| AU2003294608A1 (en) | 2004-07-22 |
| US8119614B2 (en) | 2012-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8119614B2 (en) | Substitution derivatives of N6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds | |
| AU2002363362B2 (en) | Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds | |
| AU2002363362A1 (en) | Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds | |
| JP2005508386A6 (ja) | Ｎ６−置換アデニンに基づく複素環状化合物およびその調製方法、ならびに、薬、化粧品、成長調節剤や、上記化合物を含む医薬品、化粧品、成長調節剤の調製のための使用 | |
| US10093675B2 (en) | 6,8-disubstituted-9-(heterocyclyl)purines, compositions containing these derivatives and their use in cosmetic and medicinal applications | |
| US11643413B2 (en) | 9-(2-oxacycloalkyl)-9H-purine-2,6-diamine derivatives and their use for the treatment of skin disorders | |
| EP2755977A1 (en) | 6, 8- disubstituted purine compositions and their pharmaceutical and cosmetic use | |
| US9073961B2 (en) | Substitution derivatives of N6 -benzyladenosine-5′-monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds | |
| US10100077B2 (en) | 6-aryl-9-glycosylpurines and use thereof | |
| NZ538596A (en) | Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of cosmetic, cosmetic preparations containing these compounds |